AceLink is advancing a small-molecule treatment option for Fabry disease, which could provide a more convenient alternative ...

She shared how much healthier she's become after making 'simple' change to her diet by adding one supplement to her daily ...

Fabry Disease Clinical Trial Pipeline Major pharmaceutical companies are working to advance the pipeline space and unlock the future growth ...

and then carefully construct an experiment to measure the catalytic turnovers of their test enzyme, β-galactosidase. Though many groups including Xie's had attempted to use fluorescence to study ...

Fabry disease is an X-linked lysosomal storage disorder caused by a deficiency of the enzyme α-galactosidase A (GLA), which leads to complex multisystemic involvement, with the majority of patients ...

PLX READ THE FULL PLX RESEARCH REPORT Reasons To Own / A Compelling Idea for 2025 Protalix Biotherapeutics, Inc. (NYSE:PLX) ...

GC Biopharma, a South Korean biopharmaceutical company, announced on Feb. 10th that it presented development updates on its ...